Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018

Cancer

Volumn 121, Issue 13, 2015, Pages 2281-2285

  Meester, Reinier G S ^a   Doubeni, Chyke A ^b,c   Zauber, Ann G ^d   Goede, S Luuk ^a   Levin, Theodore R ^e   Corley, Douglas A ^e   Jemal, Ahmedin ^f   Lansdorp Vogelaar, Iris ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e DIVISION OF RESEARCH   (United States)

^f AMERICAN CANCER SOCIETY   (United States)

Author keywords

cancer screening; colorectal neoplasms; incidence; mortality; public health

Indexed keywords

ARTICLE; BIOSTATISTICS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLORECTAL CANCER; FOLLOW UP; HEALTH PROGRAM; HEALTH SURVEY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; SIMULATION; STATISTICAL MODEL; UNITED STATES; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FEMALE; HUMAN; INCIDENCE; MALE; MASS SCREENING; PROCEDURES; TIME FACTOR;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; PUBLIC HEALTH; TIME FACTORS; UNITED STATES;

EID: 84931568534     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29336     Document Type: Article

References (37)

1. National Cancer Institute. SEER Cancer Statistics Factsheets: Colon and Rectum Cancer. Available at: http://seer.cancer.gov/statfacts/html/colorect.html/. Accessed September Day, 2014.
2. Siegel R, Desantis C, Jemal A., Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 104-117.
3. Edwards BK, Ward E, Kohler BA, et al., Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010; 116: 544-573.
4. Yang DX, Gross CP, Soulos PR, Yu JB., Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009. Cancer. 2014; 120: 2893-2901.
5. Centers for Disease Control and Prevention. National Health Interview Survey. Available at: http://www.cdc.gov/nchs/nhis.htm. Accessed March 1, 2014.
6. Stock C, Knudsen AB, Lansdorp-Vogelaar I, Haug U, Brenner H., Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy. Gastrointest Endosc. 2011; 73: 435-443.e5.
7. Meester RG, Doubeni CA, Lansdorp-Vogelaar I, et al., Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015; 25: 208-213.
8. American Cancer Society. The National Colorectal Cancer Roundtable. Available at: http://www.cancer.org/healthy/informationforhealthcareprofessionals/colonmdclinicansinformationsource/nationalcolorectalcancerroundtable/national-colorectal-cancer-roundtable. Accessed January 1, 2015.
9. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM., Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008; 149: 659-669.
10. Cancer Intervention and Surveillance Modeling Network (CISNET). Colorectal Cancer Model Profiles. Available at: http://cisnet.cancer.gov/colorectal/profiles.html/. Accessed January 1, 2013.
11. van Hees F, Habbema JD, Meester RG, Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG., Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med. 2014; 160: 750-759.
12. Winawer SJ, Zauber AG, Ho MN, et al., Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993; 329: 1977-1981.
13. Winawer SJ, Zauber AG, O'Brien MJ, et al., Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med. 1993; 328: 901-906.
14. Hardcastle JD, Chamberlain JO, Robinson MH, et al., Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996; 348: 1472-1477.
15. Mandel JS, Church TR, Ederer F, Bond JH., Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999; 91: 434-437.
16. Jorgensen OD, Kronborg O, Fenger C., A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002; 50: 29-32.
17. US Census Bureau. National Population Projections, 2000. Available at: http://www.census.gov/population/projections/. Accessed January day, 2015.
18. Berkeley Mortality Database. Lifetables by Year of Birth 1900-2000. Available at: http://www.demog.berkeley.edu/~bmd/states.html. Accessed January 1, 2015.
19. Surveillance Research Program, National Cancer Institute. SEER Stat Software, version 5.3.1. Available at: http://seer.cancer.gov/seerstat/. Accessed January 1, 2015.
20. Lieberman DA, Rex DK, Winawer SJ, et al,; United States Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012; 143: 844-857.
21. van Rossum LG, van Rijn AF, Laheij RJ, et al., Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008; 135: 82-90.
22. Colquhoun P, Chen HC, Kim JI, et al., High compliance rates observed for follow up colonoscopy post polypectomy are achievable outside of clinical trials: efficacy of polypectomy is not reduced by low compliance for follow up. Colorectal Dis. 2004; 6: 158-161.
23. Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A., Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2012; 21: 895-904.
24. Healthy People 2020. Disparities. Available at: http://www.healthypeople.gov/2020/about/foundation-health-measures/Disparities. Accessed January 1, 2015.
25. Ladabaum U, Song K., Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology. 2005; 129: 1151-1162.
26. Vogelaar I, van Ballegooijen M, Schrag D, et al., How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer. 2006; 107: 1624-1633.
27. Atkin WS, Edwards R, Kralj-Hans I, et al,; UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010; 375: 1624-1633.
28. Inadomi JM, Vijan S, Janz NK, et al., Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012; 172: 575-582.
29. Gupta S, Halm EA, Rockey DC, et al., Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013; 173: 1725-1732.
30. Corley DA, Jensen CD, Marks AR, et al., Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014; 370: 1298-1306.
31. Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, van Ballegooijen M, Zauber AG, Jemal A., Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev. 2012; 21: 728-736.
32. Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR., Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Clin Gastroenterol Hepatol. 2013; 11: 1158-1166.
33. Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ., Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst. 2009; 101: 1412-1422.
34. Sheffield KM, Han Y, Kuo YF, Riall TS, Goodwin JS., Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region. JAMA Intern Med. 2013; 173: 542-550.
35. Subramanian S, Tangka FK, Hoover S, et al., Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (suppl 15): 2855-2862.
36. Gupta S, Sussman DA, Doubeni CA, et al., Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst. 2014; 106: dju032.
37. Wender R,. Reaching 80% by 2018: What It's Really Going To Take [Powerpoint presentation]. Presented at The Ninth Annual New York Citywide Colon Cancer Control Coalition (C5) Summit; June 4, 2014; New York, NY. Available at: http://c5nyc.org/2014-c5-summit-presentations/#sthash.2hJy6pdA.dpuf. Accessed January 1, 2015.